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1254Objective: Resistance arteries remain subject to pulsatility, a potent regulator of large elastic artery tone and
structure, but the effect is incompletely understood. Extracorporeal circulation during cardiac surgery is often
associated with absence of pulsatility, which may affect vascular tone. To define the role of the vascular wall
in the inflammatory process that may occur with or without pulsatility, we studied resistance arteries functions
ex vivo. We measured vascular reactivity, oxidative stress, and inflammation in the arterial wall.
Methods: Isolated rat mesenteric resistance arteries were mounted in an arteriograph and subjected to pulsatility
or not in vitro. Arteries were perfused with a physiologic salt solution without circulating cells.
Results: After 180 minutes, flow-mediated dilation was higher and pressure-induced myogenic tone lower in
arteries subjected to pulsatility. Without pulsatility, reactive oxygen species and markers of inflammation
(monocyte chemotactic protein 1 and tumor necrosis factor a) were higher than baseline. In perfused mesenteric
beds under similar conditions, tumor necrosis factor awas higher in perfusate after 180minutes of nonpulsatility
(5.7  1.6 pg/mL vs 1.1  0.4 pg/mL; P < .01). In arteries treated with the antioxidant 4-hydroxy-
2,2,6,6-tetramethylpiperidin-1-oxyl (tempol), flow-mediated dilation and myogenic tone were similar in non-
pulsatile and pulsatile arteries; monocyte chemotactic protein 1 and nuclear factor kB expression levels were
not increased in tempol-treated nonpulsatile arteries.
Conclusions: Absence of pulsatility in resistance arteries increased oxidative stress, which in turn induced in-
flammation and preferentially altered pressure and flow-dependent tone, which play a key role in control of local
blood flow. (J Thorac Cardiovasc Surg 2011;142:1254-62)Cardiopulmonary bypass (CPB) is used in cardiac surgery
to allow interventions to proceed in a bloodless and non-
beating operative field. Although this surgical procedure
these days is well standardized, the potential benefit and
the precise role of pulsatile flow in CPB remain a matter
of debate. It is difficult to assess the clinical impact of pul-
satile CPB because of the lack of a precise definition and
techniques. Observational studies have reported some ben-
efits of pulsatile CPB with respect to hormonal metabolism
and postoperative outcome. Prospective randomized trials
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The Journal of Thoracic and Cardiovascular Surof pulsatile flow during CPB and aortic crossclamping.1 We
previously compared the inflammatory responses of pa-
tients undergoing coronary artery bypass grafting with ei-
ther a roller pump or a centrifugal pump delivering
nonpulsatile flow.2 We found that the terminal complement
complex activation and elastase circulating blood level
were both increased with use of the centrifugal pump as op-
posed to the conventional roller pump.3 Such results have
been observed by other researchers but to this date remain
unexplained.4 A recent study has shown that the
continuous-flow left ventricular assist device (LVAD) im-
proves end-organ renal and hepatic function in patients
with advanced heart failure5; however, controversy exists
because a higher gastrointestinal bleeding rate has been re-
ported among recipients of nonpulsatile LVADs than among
those receiving pulsatile LVADs.6
Quantification of pulsatility during CPB is a key issue, es-
pecially because the arterial pressure tracing does not neces-
sarily reflect the energy transmitted to the vascular wall.7
Although quantification of pulsatility remains controversial,
it is now well established that pulsatile flow remains present
in even the smallest arterioles.8 Indeed, pulsatile perfusion
allows efficient exchange between the vascular and extra-
vascular compartments, thus improving cellular metabo-
lism. Although pulsatility is important for proper blood
perfusion, excessive pulsatility is associated with angery c November 2011
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
FMD ¼ flow-mediated dilation
LVAD ¼ left ventricular assist device
MCP-1 ¼ monocyte chemotactic protein 1
MRA ¼ mesenteric resistance artery
NFkB ¼ nuclear factor kB
PSS ¼ physiologic salt solution
ROS ¼ reactive oxygen species
TBST ¼ Tris-buffered saline solution with
Tween
TNFa ¼ tumor necrosis factor a
Pinaud et al Perioperative Managementincreased risk of cardiovascular events.9 On the other hand,
a beneficial effect of pulsatile pressure or flow relative to
steady flow has been suggested by in vitro studies, mainly
in cultured cells. Shear stress alone stimulates release of vas-
orelaxing mediators and enhances endothelial survival. En-
dothelial cell stretch also stimulates nitric oxide release.10
Although pulsatile flowmay exert a protective effect, no ex-
periments have yet been conducted in small (resistance) ar-
teries involved in the local control of blood flow. In
resistance arteries, myogenic tone plays a key role in deter-
mining sustained vasoconstrictor tone.11 Myogenic tone is
a vasoconstriction induced by pressure in arterioles. It relies
on stretch-dependent calcium entry followed by Ras homo-
log gene family, member A–dependent sensitization of the
contractile apparatus to calcium. In the kidney, the level of
contraction obtained in response to a rise in pulsed pressure
in preglomerular arterioles is determined by the systolic
pressure, not by the mean pressure; this finding reinforces
the assumption that pulsatility is essential in the control of
microvascular tone.11 The second key issue in the control
of local blood perfusion is dilation mediated by flow (shear
stress) involving the production of vasoactive agents by the
endothelium. Flow-mediated dilation (FMD) in resistance
arteries opposes myogenic tone, thus determining a sus-
tained basal tone.11 Unlike myogenic tone, arterial re-
sponses to flow are sensitive to mechanical forces.12 We
therefore hypothesized that pressure-induced myogenic
tone and FMD are both most probably sensitive to changes
in pulsatility. We also aimed to investigate the involvement
of inflammatory factors and reactive oxygen species (ROS)
in the changes in vascular tone that are associated with re-
duced pulsatility.P
MMATERIALS AND METHODS
Arteries and Study Groups
Four-month-old adult Wistar male rats were anesthetized with isoflur-
ane (5%) and humanely killed with inhaled carbon dioxide. The mesentery
was then removed to isolate the mesenteric resistance arteries (MRAs). AThe Journal of Thoracic and Carsegment of MRA approximately 200 mm in external diameter was cannu-
lated at both ends and mounted in a video-monitored perfusion system as
previously described.13 Briefly, cannulated arterial segments were bathed
in a 5-mL organ bath containing a physiologic salt solution (PSS) of the fol-
lowing composition: 135.0-mmol/L sodium chloride, 15.0-mmol/L sodium
hydrogen carbonate, 4.6-mmol/L potassium chloride, 1.5-mmol/L calcium
chloride; 1.2-mmol/L magnesium sulfate, 11.0-mmol/L glucose, and 10.0-
mol/L, N-2-hydroxy-ethylpiperazine-N-20-ethylsulfonic acid. The pH was
maintained at 7.4, the PO2 at 160 mm Hg, and the PCO2 at 37 mm Hg. Ar-
teries were subjected to a pressure of 50 mm Hg. Arterial diameter was
measured and recorded continuously with a video monitoring system (Liv-
ing System Instrumentation Inc, Burlington, Vt). Pressure and flow rate
could be changed independently. A rolling pump was connected to the tub-
ing upstream of the artery to generate pulsatility (300 beats/min; Figure 1).
In vivo carotid artery pulsatility (Figure 1, A) was compared with the pul-
satility measured in vitro in the rat model (Figure 1, B). Arteries were sub-
jected to pulsatile or nonpulsatile conditions (nonpulsatile control) for 30 to
180 minutes. Endothelial and smooth muscle cells functions were then
studied, as were biochemical and immunohistochemical factors.
Arterial Tone
Pressure-mediated myogenic tone and FMD were determined as previ-
ously described elsewhere.14 In brief, diameter changes at equilibrium
were measured when intraluminal pressures were set at 10, 25, 50, 75,
100, 125, and 150 mm Hg. Arteries were then subjected to 50 mm Hg of
pressure and further contracted with phenylephrine (1 mmol/L). Intralumi-
nal flow was then increased by steps (from 0 to 100 mL/min), and the diam-
eter was measured to determine FMD.14 At the end of each experiment,
arteries were perfused and superfused with a calcium-free PSS containing
ethylene glycol tetraacetic acid (2 mmol/L) and sodium nitroprusside (100
mmol/L). Pressure steps (from 10 to 150 mm Hg) were then repeated to de-
termine the passive diameter of the vessel in the absence of smooth muscle
tone. Diameter measurements made in normal PSS were considered to rep-
resent the diameter under active tone, or the active diameter. Pressure and
diameter measurements were collected with a Biopac data-acquisition sys-
tem (Biopac MP 100; BIOPAC Systems, Inc, Goleta, Calif) and analyzed
(Acqknowledge software; BIOPAC Systems). Myogenic tone was calcu-
lated as the percentage of passive diameter, and FMD was expressed as
the percentage dilation of active tone.14
PerfusedWholeMesenteric Bed andMeasurement of
Tumor Necrosis Factor a in Perfusate
Rats were anesthetized with isoflurane (5%). The abdomenwas opened,
and the superior mesenteric artery was cannulated with polyethylene 90
tubing. Heparinized saline solutionwas flushed through themesenteric vas-
cular bed. The vascular bed was then dissected free from the intestine along
the intestinal wall and placed in an organ bath maintained at 37C; it was
then perfused and superfused with the PSS described previously at a rate of
2 mL/min. Pulsatility was generated with the rolling pump as described
previously in the perfused arteries. The preparation was allowed to equili-
brate for 45 minutes before experimentation began. The PSS was then col-
lected after 30, 90, or 180 minutes of perfusion with or without pulsatility.
Perfusate tumor necrosis factor a (TNFa) concentration was measured
with a commercially available kit (Cayman Chemical Company, Ann
Arbor, Mich).
Western Blot Analyses of Monocyte Chemotactic
Protein 1 and Nuclear Factor kB
Western blot analyses of monocyte chemotactic protein 1 (MCP-1, an
endothelial activation marker) and nuclear factor kB (NFkB) were per-
formed in MRAs as previously described elsewhere.12 The MRAs (8 rats
per group) were homogenized with a lysis buffer (1% sodium dodecyl sul-
fate, 10-mmol/L tris[hydroxymethyl]aminomethane hydrochloride at pHdiovascular Surgery c Volume 142, Number 5 1255
FIGURE 1. Typical recording showing blood pressure measurements ob-
tained in vivo in the carotid artery (A) and those obtained in a mesenteric
resistance artery perfused in vitro in an arteriograph and subjected to pul-
satility (B). When pulsatility was started (arrow, C), pulsatility was detect-
able both on the diameter recording (C) and on the pressure recording (D).
Corresponding control recordings (artery without pulsatility) are shown for
diameter (E) and pressure (F). The lower panel (G) shows diameter
changes in response to pulsatility (red trace) relative to nonpulsatile ar-
teries. Pulsatility was maintained for 180 minutes. Data are presented as
mean  SEM (n ¼ 10 rats per group).
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M7.4, 1-mmol/L sodium orthovanadate, 2.5-mg/L leupeptin, and 5-mg/L
aprotinin). Extracts were incubated at 25C for 30 minutes and then centri-
fuged (1000 g, 15 minutes, 14C). Protein concentration was determined
with the Micro BCA Protein Assay Kit (Pierce; Thermo Fisher Scientific
Inc, Rockford, Ill). After denaturation at 100C for 5 minutes, equal
amounts of proteins (15 mg) were loaded on a 9% polyacrylamide gel
and transferred to nitrocellulose membranes for 12 hours (40 V, 4C).
Membranes were blocked with 10% bovine serum albumin in Tris-
buffered saline solution with Tween (TBST, 20-mmol/L tris[hydroxy-
methyl]aminomethane at pH 8.0, 150-mmol/L sodium chloride, and
0.1% polysorbate 20) for 1 hour and were then incubated with anti–
MCP-1 (1/100; BD Pharmingen,) and anti-NFkB (1/100 BD Pharmingen;
Becton, Dickinson and Company, Franklin Lakes, NJ) antibodies for 1 hour
at room temperature. After 3 washes with TBST, immunocomplexes were1256 The Journal of Thoracic and Cardiovascular Surdetected by chemiluminescent reaction (ECL-kit; GE Healthcare Life Sci-
ences, Little Chalfont, UK) with a computer-based imaging system (Fuji
LAS 1000 plus; FUJIFILM Medical Systems USA, Inc, Stamford,
Conn). Quantification was performed by densitometric analysis.
Detection of ROS by Confocal Microscopy in MRAs
ROS detection was performed on transverse cross sections 7-mm thick
with dihydroethydine and microfluoroscopy, as previously described else-
where.15 Eight different arteries from 8 different rats were used in each
group. Fluorescence of the wall after incubation with dihydroethydine
was measured with confocal microscopy to allow quantification with
QED image software (Solamere Technology Group Inc, Salt Lake City,
Utah). At least 5 measurements were performed per slice and averaged,
and at least 5 slices were analyzed per artery.
Immunofluorescence Analysis
Segments of MRAs (n ¼ 6 rats per group) were mounted in embedding
medium (Sakura Finetek USA, Inc, Torrance, Calif), frozen in isopentane
that had been cooled in liquid nitrogen, and stored at80C in 7-mm thick
cross sections. Sections were incubated with anti-TNFa antibodies (1/100
sc1351; Santa Cruz Biotechnology, Inc, Santa Cruz, Calif) or anti–MCP-1
antibodies (1/100 554444 BD Pharmingen; Becton Dickinson). Control ex-
periments were performed after incubation without the first antibody, and
positive experiments were performed with arterial sections from rats
treated with lipopolysaccharide.15 Fluorescence staining was then visual-
ized with confocal microscopy (Solamere Technology), followed by pixel
quantification as previously described elsewhere.15 At least 5 measure-
ments were performed per slice and averaged, and at least 5 slices were an-
alyzed per artery.
Statistical Analysis
Results are expressed as mean  SEM. Significance of differences be-
tween groups was determined by analysis of variance (1-factor analysis of
variance or analysis of variance for consecutive measurements as
appropriate).
Animal Care
The procedures followed in the care and humane killing of the study an-
imals were all in accordance with the European Community Standards on
the Care and Use of Laboratory Animals (Ministere de l’Agriculture,
France, authorization 6422).RESULTS
In isolated rat MRAs, pulsatile pressure (Figure 1, D) in-
duced significant dilation (Figure 1, C). In the time control
experiment, no significant change in diameter was observed
throughout the duration of the experiment (Figure 1, E–F).
When pulsatility was stopped after 180 minutes, arterial di-
ameter returned to baseline (Figure 1, G). Stepwise in-
creases in flow (shear stress) induced progressive dilation
(Figure 2, A), and stepwise increases in pressure induced
contraction or myogenic tone (Figure 2, B). FMD was sig-
nificantly lower (P< .01) under nonpulsatile conditions
than in arteries subjected to pulsatility for 180 minutes.
No difference was observed between pulsatile and nonpul-
satile conditions after 30 minutes (Figure 2, A). In contrast,
myogenic tone was significantly higher in the absence of
pulsatility after 180 minutes but not after 30 minutes
(P < .05; Figure 2, B). In the absence of pulsatility,gery c November 2011
FIGURE 2. Flow-mediated dilation (A) and myogenic tone (B) in mesenteric resistance arteries subjected to pulsatile (P) or nonpulsatile (NP) conditions
for 30 (left panel) or 180 (right panel) minutes. Data are presented as mean  SEM (n ¼ 10 rats per group). Asterisk indicates P<.01 for pulsatile versus
nonpulsatile conditions.
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Ma significant ROS level (which was higher after 180 minutes
than after 30 minutes) was found in the arterial wall
(P< .05). No significant amounts of ROS were detected
in arteries subjected to pulsatility (Figure 3). With immuno-
histochemical methods, we found that MCP-1 (Figure 4, A)
and TNFa (Figure 4, B) productions were significant in ar-
teries subjected to nonpulsatile conditions after 180 minutes
but not after 30 minutes. Under nonpulsatile conditions for
90 and 180 minutes, the quantity of TNFa in the perfusate
of whole mesenteric arterial beds was significantly in-
creased (P<.05) relative to that seen under pulsatile condi-
tions (Figure 4, C). In arteries treated in advance with the
antioxidant 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl
(tempol), pulsatility induced dilation (Figure 5, A). After
incubation in the presence of tempol for either 30 or 180
minutes, FMD and myogenic tone were similar between ar-
teries subjected to pulsatile and nonpulsatile conditions
(Figure 5, B and C). In the presence of tempol, the increases
in MCP-1 and NFkB protein levels otherwise associated
with the absence of pulsatility were not observed
(Figure 5, D and E).
DISCUSSION
This is the first time that a study has identified a mecha-
nism for the alteration in vascular reactivity induced by the
absence of pulsatility in isolated resistance arteries. We
found that the oxidative stress that was induced initially
was followed by inflammation and changes in vascularThe Journal of Thoracic and Cartone, with increased myogenic tone and reduced FMD,
thus favoring alteration in blood flow. The experimental
setup we used allowed the arteries to be subjected to pulsa-
tile or nonpulsatile conditions while controlling pressure
and flow and also eliminating any influences of circulating
cells and surrounding tissues. Under these conditions,
changes occurring in the absence of pulsatility could be at-
tributable only to a response in the vascular wall. This pro-
vides new insights into the systemic inflammatory response
seen after cardiac surgery, which has generally been be-
lieved to be a process generated by blood cell activation.16
Controversial findings have been described in clinical tri-
als.17 Some authors have reported that pulsatile CPB im-
proves postoperative outcome, whereas others consider
that linear flow might be well tolerated in clinical practice.
In particular, clinical experiences with patients in whom
pulseless LVADs (which provide totally linear flow) have
been implanted support this belief.5 There are marked dif-
ferences, however, between the clinical and surgical set-
tings of patients with LVADs and those of patients
undergoing routine CPB for cardiac surgery.18 It is impor-
tant to isolate the effects of the absence of pulsatility in
the surgical contexts in which various protocols and devices
(pumps, oxygenators, filter, etc) may be used.19 This persis-
tent controversy led us to study the effect of pulsatility alone
in isolated arteries in vitro.
First, we found that FMD was selectively reduced and
that myogenic tone was higher in arteries exposed todiovascular Surgery c Volume 142, Number 5 1257
FIGURE 3. Reactive oxygen species (ROS) detection with dihydroethydine (DHE). Reactive oxygen species level was determined in mesenteric resistance
arteries subjected to pulsatile (P) or nonpulsatile (NP) conditions for 0, 30, or 180 minutes. Data are presented as mean  SEM (n ¼ 10 rats per group).
Asterisk indicates P<.01 for pulsatile versus nonpulsatile conditions.
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cular reactivity argue in favor of a vasospastic phenotype.
Because myogenic tone and FMD are sensitive to ROS1258 The Journal of Thoracic and Cardiovascular Surproduction, we measured ROS concentrations in the ar-
teries subjected to pulsatile or nonpulsatile conditions. In-
deed, a rise in ROS production in both endothelial andgery c November 2011
FIGURE 4. Monocyte chemotactic protein 1 (MCP-1, A) and tumor necrosis factor a (TNFa, B) levels were determined with immunohistochemical
methods (IHC) in mesenteric resistance arteries subjected to pulsatile or nonpulsatile conditions for 30 or 180 minutes. Typical images are shown on
the left side. Positive (Pos.) and negative (Neg.) controls are shown for each protein. Tumor necrosis factor a level was then measured in the perfusate
of whole mesenteric arterial beds perfused under pulsatile or nonpulsatile conditions (C). Perfusate was collected after 30, 90, and 180 minutes. Data
are presented as mean  SEM (n ¼ 10 rats per group). Asterisk indicates P<.01 for pulsatile versus nonpulsatile conditions.
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Msmooth muscle cells might be the cause of the vasospastic-
ity observed in nonpulsatile arteries. Myogenic tone and
FMD both play key roles in the control of local blood
flow, especially in organs with tightly controlled blood
flow autoregulation. In the cerebral circulation, forThe Journal of Thoracic and Carexample, myogenic tone and FMD closely interact to con-
trol blood flow.20 We have shown that myogenic tone and
FMD were affected (increased and reduced, respectively)
at a very early stage in CADASIL (cerebral autosomal
dominant arteriopathy with subcortical infarcts anddiovascular Surgery c Volume 142, Number 5 1259
FIGURE 5. Effect of treatment with the antioxidant tempol on pulsatility-induced dilation (A), on flow-mediated dilation (B and D), and on myogenic tone
(C and E). Nuclear factor kB (NFkB, F) and monocyte chemotactic protein 1 (MCP-1,G) protein levels were measured in arterial walls subjected to pulsatile
(P) or nonpulsatile (NP) conditions in the presence or absence of tempol. Flow-mediated dilation and myogenic tone were determined after 30 (B and C) or
180 (D and E) minutes. Protein level was determined with Western blot analysis. Data are presented as mean  SEM (n ¼ 10 rats per group). Asterisk in-
dicates P<.01 for pulsatile versus nonpulsatile conditions. Hatch mark indicates P<.01 for the effect of tempol.
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Mleukoencephalopathy) syndromes, which are characterized
by reduced blood flow to the brain and eventually by irre-
versible dementia.21 Similarly, FMD is the hallmark of en-
dothelial disorders with a reduced dilatory response,
occurring at an early stage in most cardiovascular and met-
abolic diseases that are associated with vascular dysfunc-
tion.22 The hypothesis that an excessive production of
ROS might increase myogenic tone and reduce FMD is
strongly supported by our data, which show that treating
arteries with the antioxidant tempol could prevent the1260 The Journal of Thoracic and Cardiovascular Surchanges in vascular reactivity induced by different pulsa-
tile conditions. We also found inflammatory factors
(MCP-1, TNFa, and NFkB) in arteries subjected to non-
pulsatile conditions. To confirm this inflammation, we
measured the production of TNFa in the perfusate of
a whole mesenteric bed and found it to be significantly
elevated in the absence of pulsatility. These findings are
in agreement with those of a previous study conducted
in patients undergoing coronary artery bypass grafting,
which showed that endotoxemia (caused by bacterialgery c November 2011
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Mtranslocation from splanchnic hypoperfusion and injury)
was increased in patients undergoing nonpulsatile CPB.23
It is interesting that this elevation was more pronounced
during aortic crossclamping than throughout the duration
of CPB itself, because the native pulsatility from the beat-
ing heart was completely abolished by cardioplegic arrest.
The residual pulsatile flow in this condition was provided
only by the arterial pump used for CPB. This is a condition
that is not encountered during long-term circulatory sup-
port,18 because the heart does not need to be arrested as
it is during heart surgery. This may explain the fairly
good results with respect to end-organ function, such as
those recently published by Russell and colleagues,5
when native pulsatile oscillatory activity generated by
the beating (although not working) heart is still present
in recipients of nonpulsatile LVAD. Onorati and col-
leagues24 have reported on a series of clinical studies
maintaining the use of an intra-aortic balloon pump during
aortic crossclamping in CPB in critically ill patients. They
found that some intra-aortic balloon pump–induced pulsa-
tile perfusion during this critical period was associated
with a reduction in inflammatory response (particularly
MCP-1) relative to that observed after nonphysiologic lin-
ear perfusion.24 The oscillatory energy provided by pulsa-
tile flow may protect the endothelial cells, which are
normally exposed and presumably adapted to a normal
level of shear stress in the range of 5 to 20 dyn/cm2.25 Fol-
lowing this reasoning, the inflammatory response would be
generated at the endothelial level, which is consistent with
our results reported here. Until now, the surgical literature
has considered the inflammatory response to be a blood
cell and plasma activation process, with subsequent micro-
circulatory injury. We found that pulsatility in itself was
protective. In the absence of flow, the residual pulsatility
imposed by the roller pump was sufficient to prevent the
changes in myogenic tone and FMD that were seen in
the absence of pulsatility. Similarly, in no-flow conditions
but with pulsatility, ROS, MCP-1, TNF a, and NFkB were
not found in arteries even after 3 hours. Steady shear stress
activates phosphoinositide-3 kinase, leading to phosphory-
lation and activation of Akt in isolated cells.26 Activated
Akt in turn phosphorylates nitric oxide synthase, contribut-
ing to sustained nitric oxide release and stimulating
kinases and transcription factors to increase cytoprotec-
tion.26 Cyclic stretch also enhances Akt activity,27 and
when both stimuli are combined, as with pulsatile perfu-
sion in a compliant conduit, Akt and nitric oxide synthase
phosphorylation are further increased.28
Finally, we found that inflammation could be detected af-
ter 3 hours in the arterial wall or after 90 minutes in the per-
fusate, whereas ROS levels were significantly elevated after
30 minutes in the absence of pulsatility. This finding sug-
gests that ROS production might precede and possibly
even induce inflammation. This speculation is confirmedThe Journal of Thoracic and Carby our data showing that the treatment of the arteries with
an antioxidant prevented the rise in ROS level and inflam-
mation within the mesenteric arteries. Thus ROS production
induced by the absence of pulsatility in turn induced both
inflammation and a change in vascular reactivity in favor
of vasospasm. Nevertheless, our study does not allow in-
volvement of the inflammatory response in the change in
vascular reactivity. Indeed, inflammation is rather known
to induce vasodilatation.References
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